{"id":"propofol-injectable-emulsion","safety":{"commonSideEffects":[{"rate":"25-30","effect":"Hypotension"},{"rate":"20-30","effect":"Respiratory depression"},{"rate":"10-20","effect":"Pain on injection"},{"rate":"5-10","effect":"Bradycardia"},{"rate":"5-10","effect":"Apnea"},{"rate":null,"effect":"Propofol infusion syndrome (with prolonged use)"}]},"_chembl":{"chemblId":"CHEMBL526","moleculeType":"Small molecule","molecularWeight":"178.27"},"_dailymed":{"setId":"631b08c8-ce97-4a04-8bd4-18463088f30a","title":"PROPOVAN 28 (PROPOFOL INJECTABLE EMULSION) INJECTION, EMULSION [MWI VETERINARY SUPPLY]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Propofol acts as a positive allosteric modulator of GABA-A receptors, increasing chloride ion influx and neuronal hyperpolarization. This results in rapid onset of sedation and anesthesia. It is commonly used for induction and maintenance of general anesthesia, as well as for sedation in intensive care settings.","oneSentence":"Propofol is a sedative-hypnotic agent that enhances inhibitory GABA neurotransmission in the central nervous system to produce rapid unconsciousness and sedation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T05:23:03.139Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Induction of general anesthesia"},{"name":"Maintenance of general anesthesia"},{"name":"Sedation in mechanically ventilated patients in intensive care units"}]},"trialDetails":[{"nctId":"NCT07336628","phase":"NA","title":"Propofol vs Remifentanil for Sedation in Gastroscopy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fatih Sultan Mehmet Training and Research Hospital","startDate":"2025-11-01","conditions":"Conscious Sedation, Procedural Sedation","enrollment":80},{"nctId":"NCT06222294","phase":"PHASE3","title":"A Study of Remimazolam Tosilate for Sedation in the ICU","status":"COMPLETED","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2024-03-12","conditions":"Sedation in the ICU","enrollment":214},{"nctId":"NCT05478174","phase":"PHASE3","title":"Efficacy and Safety of HSK3486 Compared to Propofol for Adults Undergoing Elective Surgery With General Anesthesia","status":"COMPLETED","sponsor":"Haisco-USA Pharmaceuticals, Inc.","startDate":"2022-07-26","conditions":"General Anesthesia","enrollment":400},{"nctId":"NCT05486416","phase":"PHASE3","title":"Safety and Efficacy of HSK3486 Compared to Propofol for Induction of General Anesthesia in Adults With Elective Surgery","status":"COMPLETED","sponsor":"Haisco-USA Pharmaceuticals, Inc.","startDate":"2024-01-12","conditions":"General Anesthesia","enrollment":465},{"nctId":"NCT04711837","phase":"PHASE3","title":"Efficacy and Safety of HSK3486 Compared to Propofol in Induction of General Anesthesia in Adults Having Elective Surgery","status":"COMPLETED","sponsor":"Haisco-USA Pharmaceuticals, Inc.","startDate":"2021-02-11","conditions":"Anesthesia","enrollment":255},{"nctId":"NCT07057609","phase":"PHASE1","title":"Bioequivalence Study of Propofol Medium and Long Chain Fat Emulsion Injection in Healthy Chinese Subjects","status":"COMPLETED","sponsor":"Haisco Pharmaceutical Group Co., Ltd.","startDate":"2018-10-16","conditions":"Healthy","enrollment":36},{"nctId":"NCT04016246","phase":"PHASE3","title":"Respiratory Effect of the LISA Method with Sedation by Propofol Versus Absence of Sedation.","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Grenoble","startDate":"2019-10-07","conditions":"Respiratory Distress Syndrome in Premature Infant","enrollment":233},{"nctId":"NCT06332157","phase":"NA","title":"Postoperative Quality of Recovery After General Anesthesia With Remimazolam","status":"UNKNOWN","sponsor":"Beijing Chao Yang Hospital","startDate":"2024-09","conditions":"Anesthesia Recovery Period","enrollment":126},{"nctId":"NCT05223907","phase":"PHASE4","title":"Safety and Efficacy of Maintenance of Etomidate in General Anesthesia","status":"COMPLETED","sponsor":"Henan Provincial People's Hospital","startDate":"2021-05-01","conditions":"General Anesthesia","enrollment":1080},{"nctId":"NCT06207344","phase":"NA","title":"The Anesthesia Effects of Dexmedetomidine Combined With Desflurane or Propofol in Lobectomy","status":"RECRUITING","sponsor":"The Second Affiliated Hospital of Chongqing Medical University","startDate":"2023-10-21","conditions":"Anesthesia Recovery Period, Postoperative Complications","enrollment":120},{"nctId":"NCT05658692","phase":"PHASE4","title":"Platform Adaptive Embedded Trial for Acute Respiratory Distress Syndrome","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2022-10-01","conditions":"Acute Respiratory Distress Syndrome","enrollment":1000},{"nctId":"NCT01369147","phase":"PHASE2","title":"The Energy Dose Study","status":"TERMINATED","sponsor":"Emory University","startDate":"2011-07","conditions":"Critical Illness","enrollment":12},{"nctId":"NCT04511728","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of HSK3486 in the Induction of General Anesthesia","status":"COMPLETED","sponsor":"Haisco Pharmaceutical Group Co., Ltd.","startDate":"2020-11-24","conditions":"Induction and Maintenance of General Anesthesia","enrollment":129},{"nctId":"NCT04620031","phase":"PHASE3","title":"A Study Evaluating Sedation of Intravenous Administration of HSK3486 Injectable Emulsion in ICU Patients Undergoing Mechanical Ventilation","status":"COMPLETED","sponsor":"Haisco Pharmaceutical Group Co., Ltd.","startDate":"2020-12-08","conditions":"Sedation in Intensive Care","enrollment":135},{"nctId":"NCT04147416","phase":"PHASE2","title":"A Study Evaluating the Efficacy and Safety of HSK3486 for Sedation","status":"COMPLETED","sponsor":"Sichuan Haisco Pharmaceutical Group Co., Ltd","startDate":"2019-11-22","conditions":"Sedation","enrollment":39},{"nctId":"NCT04669821","phase":"PHASE2","title":"A Clinical Study Evaluating Sedation of Intravenous Administration of HSK3486 in ICU Patients Undergoing Long-Term Mechanical Ventilation","status":"COMPLETED","sponsor":"Haisco Pharmaceutical Group Co., Ltd.","startDate":"2021-03-09","conditions":"Sedation in Intensive Care","enrollment":20},{"nctId":"NCT04048811","phase":"PHASE2","title":"A Clinical Trial Evaluating the Efficacy and Safety of HSK3486 Injectable Emulsion in Elective Surgery Patients","status":"COMPLETED","sponsor":"Sichuan Haisco Pharmaceutical Group Co., Ltd","startDate":"2019-12-09","conditions":"Induction and Maintenance of General Anesthesia","enrollment":46},{"nctId":"NCT04111159","phase":"PHASE3","title":"A Trial Evaluating the Efficacy and Safety of HSK3486 Injectable Emulsion in Subjects Undergoing Fiberoptic Bronchoscopy","status":"COMPLETED","sponsor":"Sichuan Haisco Pharmaceutical Group Co., Ltd","startDate":"2019-12-06","conditions":"Sedation or Anesthesia","enrollment":267},{"nctId":"NCT03745625","phase":"PHASE1","title":"A Study Evaluating the Safety and Pharmacokinetics/Pharmacodynamics of HSK3486","status":"COMPLETED","sponsor":"Sichuan Haisco Pharmaceutical Group Co., Ltd","startDate":"2019-01-09","conditions":"Anesthesia, Sedation","enrollment":16},{"nctId":"NCT03808844","phase":"PHASE3","title":"A Trial Evaluating the Efficacy and Safety of HSK3486 Injectable Emulsion for the Induction of General Anesthesia in Elective Surgery Subjects","status":"COMPLETED","sponsor":"Sichuan Haisco Pharmaceutical Group Co., Ltd","startDate":"2019-03-22","conditions":"Induction of Anesthesia","enrollment":178},{"nctId":"NCT03773042","phase":"PHASE2","title":"A Study Evaluating Tolerability, Efficacy, and Safety of HSK3486 Injectable Emulsion in Patients","status":"COMPLETED","sponsor":"Sichuan Haisco Pharmaceutical Group Co., Ltd","startDate":"2016-12","conditions":"Colonoscopy","enrollment":64},{"nctId":"NCT01401049","phase":"PHASE4","title":"Preventing Propofol Injection Pain: Prospective Randomized Trial Comparing Propofol Versus Fospropofol","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2010-08","conditions":"Complication of Injection, Pain","enrollment":116},{"nctId":"NCT02602743","phase":"PHASE4","title":"Propofol-Ketamine vs Remifentanyl-Ketamine for Sedation in Pediatric Patients Undergoing Colonoscopy","status":"COMPLETED","sponsor":"Cukurova University","startDate":"2016-08","conditions":"Delayed Emergence From Anesthesia","enrollment":70},{"nctId":"NCT01260142","phase":"PHASE4","title":"A PK/PD Study of Fospropofol Disodium Compared With Propofol Injectable Emulsion","status":"COMPLETED","sponsor":"Eisai Inc.","startDate":"2010-11","conditions":"Anesthesia","enrollment":36},{"nctId":"NCT02659228","phase":"NA","title":"Assessing Covert Consciousness in Unresponsive Patients","status":"UNKNOWN","sponsor":"University of Michigan","startDate":"2016-12","conditions":"Consciousness Disorders","enrollment":60},{"nctId":"NCT02043977","phase":"PHASE1","title":"Efficacy and Safety Study of Propofol Infusion for Refractory Chronic Primary Insomnia","status":"COMPLETED","sponsor":"Life Extension Foundation Inc.","startDate":"2013-06","conditions":"Insomnia, Sleep Disorder, Dyssomnia","enrollment":2},{"nctId":"NCT02713802","phase":"PHASE1","title":"Pilot Study of Bioequivalence of Cudafol(R) and Diprivan(R) Administered as Single Intravenous Doses in Healthy Subjects","status":"COMPLETED","sponsor":"Cuda Anesthetics, LLC","startDate":"2016-03","conditions":"Healthy Subjects","enrollment":8},{"nctId":"NCT01308541","phase":"PHASE1","title":"A Study to Characterize Pharmacokinetics (PK) and Pharmacodynamics (PD) of LUSEDRA® Administered as Continuous Infusion or Bolus Compared With Continuous Infusion of Propofol Injectable Emulsion","status":"COMPLETED","sponsor":"Eisai Inc.","startDate":"2011-01","conditions":"Monitored Anesthesia Care","enrollment":20},{"nctId":"NCT02518789","phase":"PHASE4","title":"Effects and Mechanism of Pretreatment With Dexmedetomidine to Etomidate Induce Myoclonus","status":"UNKNOWN","sponsor":"Tang-Du Hospital","startDate":"2015-09","conditions":"Myoclonus","enrollment":132},{"nctId":"NCT02013986","phase":"PHASE4","title":"Effects of Etomidate on Postoperative Circadian Rhythm Changes of Salivary Cortisol in Children","status":"UNKNOWN","sponsor":"Du yi","startDate":"2013-09","conditions":"Congenital Hydronephrosis, Congenital Choledochal Cyst, Fracture","enrollment":30},{"nctId":"NCT01913054","phase":"PHASE4","title":"Combined Use of Etomidate and Propofol in Painless Gastroscopy.","status":"UNKNOWN","sponsor":"Jiangsu Nhwa Pharmaceutical Co., Ltd.","startDate":"2013-08","conditions":"Safety of Gastroscopy","enrollment":2450},{"nctId":"NCT01729897","phase":"NA","title":"Etomidate Emulsion for Sedation in Patients Scheduled for Upper Gastrointestinal (GI) Endoscopy","status":"COMPLETED","sponsor":"Jiangsu Nhwa Pharmaceutical Co., Ltd.","startDate":"2012-05","conditions":"Complication of Gastrostomy","enrollment":328},{"nctId":"NCT00690495","phase":"PHASE3","title":"Use of a Modified Propofol Emulsion in Adults","status":"COMPLETED","sponsor":"B. Braun Melsungen AG","startDate":"2008-05","conditions":"Anesthesia","enrollment":100},{"nctId":"NCT00209521","phase":"PHASE2","title":"Comparison of AQUAVAN® Injection to DISOPRIVAN® Injectable Emulsion for Anesthesia During Coronary Artery Surgery","status":"COMPLETED","sponsor":"Eisai Inc.","startDate":"2002-06","conditions":"Ischemic Coronary Artery Disease, Coronary Artery Bypass Surgery","enrollment":16}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[{"date":"20230830","type":"SUPPL","sponsor":"DR REDDYS","applicationNumber":"ANDA205067"},{"date":"20181115","type":"ORIG","sponsor":"DR REDDYS","applicationNumber":"ANDA205067"}],"publicationCount":5,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"propofol injectable emulsion","genericName":"propofol injectable emulsion","companyName":"Life Extension Foundation Inc.","companyId":"life-extension-foundation-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Propofol is a sedative-hypnotic agent that enhances inhibitory GABA neurotransmission in the central nervous system to produce rapid unconsciousness and sedation. Used for Induction of general anesthesia, Maintenance of general anesthesia, Sedation in mechanically ventilated patients in intensive care units.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}